The REVERSE-HF study is a randomized controlled trial to evaluate clinical outcomes of adjustable ultrafiltration with the Aquadex System as compared to adjustable IV loop diuretics in patients with worsening heart failure (HF) and fluid overload.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
167
ultrafiltration
diuretics
Banner Health
Tucson, Arizona, United States
MemorialCare, Long Beach Medical Center
Long Beach, California, United States
Time to first heart failure (HF) event
Heart Failure (HF) event defined as any HF rehospitalization or unplanned use of IV loop diuretics, vasoactive medications or Aquadex therapy in any outpatient setting.
Time frame: within 30 days
Win ratio analysis
Win ratio analysis of cardiovascular (CV) mortality, HF events and quality of life
Time frame: within 30 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Sharp Memorial Hospital, San Diego Cardiac Center
San Diego, California, United States
BayCare Medical Group, Morton Plant
Clearwater, Florida, United States
University of Kentucky
Lexington, Kentucky, United States
Henry Ford Health
Detroit, Michigan, United States
Mount Sinai Morningside
New York, New York, United States
The Mount Sinai Hospital
New York, New York, United States
Northwell Health
New York, New York, United States
The Christ Hospital
Cincinnati, Ohio, United States
...and 5 more locations